Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload
Despite the promising results of serelaxin as a new potential acute heart failure (HF) therapy, its clinical use preceded the understanding of the endogenous relaxin system in HF. We aimed to evaluate relaxin circulating levels in a population of acute HF and their association with clinical and echocardiographic parameters.
European journal of heart failure